DENTSPLY SIRONA (XRAY) Leerink Global Healthcare Conference 2026 summary
Event summary combining transcript, slides, and related documents.
Leerink Global Healthcare Conference 2026 summary
10 Mar, 2026Strategic priorities and progress tracking
Focus on urgency and day-to-day progress, with key metrics around dealer engagement and clinical education volume as leading indicators for U.S. business health.
Simplified dealer relationships and dropship models aim to improve efficiency, cash flow, and inventory management.
Emphasis on transparent communication, bold decision-making, and holistic business health over short-term profitability.
Restructuring and investments are expected to create near-term EPS pressure, with anticipated benefits in the second half of the year.
Plans to de-leverage and use cash flow for share repurchases to drive EPS growth.
Product and innovation strategy
Incremental R&D is now strategically focused, accelerating DS Core software development across multiple verticals and modernizing the EDS portfolio.
AI and robotics are being integrated into product development and workflow enhancements, with AI also targeted for internal efficiency gains.
Primescan 3 is in conceptual stages, aiming for smaller, faster, and more affordable intraoral scanners.
SureSmile orthodontic platform is being modernized, with R&D focused on software upgrades and clinical education to regain market share.
No significant product gaps identified; execution and communication are the main areas for improvement.
Commercial and market execution
Renewed dealer partnerships and simplified deal structures are designed to align incentives and drive volume.
Clinical education and rep training are prioritized, especially for implants and ortho, with a med device-style approach to rep development.
DSO (Dental Service Organization) strategy is being sequenced, with a dedicated team and structure expected in the next six months.
Promotional partnerships with dealers are favored, provided there are volume commitments to justify price relief.
EMEA is the strongest region for implants, with Asia Pacific seen as the highest potential growth market.
Latest events from DENTSPLY SIRONA
- Q4 2025 sales rose but FY 2025 declined; restructuring and dividend cut shift focus to growth.XRAY
Q4 202527 Feb 2026 - All proposals, including director elections and incentive plan amendment, were approved by majority vote.XRAY
AGM 20253 Feb 2026 - Transformation and digitalization drive growth, but implants continue to underperform.XRAY
43rd Annual J.P. Morgan Healthcare Conference 20253 Feb 2026 - Q2 sales fell 4.2% to $984M, with a net loss and new cost-saving restructuring underway.XRAY
Q2 20242 Feb 2026 - Transformation and digitalization target $200M+ savings and 500 bps margin growth by 2026.XRAY
The 44th Annual William Blair Growth Stock Conference1 Feb 2026 - Primescan 2 launch and operational streamlining drive digital growth amid muted dental demand.XRAY
Morgan Stanley 22nd Annual Global Healthcare Conference22 Jan 2026 - Digital transformation and cloud innovation drive growth amid ongoing restructuring and market shifts.XRAY
Baird's 2024 Global Healthcare Conference21 Jan 2026 - Q3 sales rose 1.3%, but Byte suspension and a $495M impairment drove a $494M net loss.XRAY
Q3 202416 Jan 2026 - Turnaround plan drives digital innovation, DS Core expansion, and US growth in a $33B market.XRAY
44th Annual J.P. Morgan Healthcare Conference14 Jan 2026